v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Non-controlling Interest
Beginning Balance (in shares) at Dec. 31, 2024   88,853,150      
Beginning Balance at Dec. 31, 2024 $ 162,425 $ 889 $ 285,167 $ (123,868) $ 237
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (6,284)     (5,985) (299)
Restricted stock grant canceled (in shares)   (115,312)      
Restricted stock grant canceled 0 $ (1) 1    
Stock-based compensation 2,035   2,035    
Ending Balance (in shares) at Mar. 31, 2025   88,737,838      
Ending Balance at Mar. 31, 2025 $ 158,176 $ 888 287,203 (129,853) (62)
Beginning Balance (in shares) at Dec. 31, 2025 88,247,942 88,247,942      
Beginning Balance at Dec. 31, 2025 $ 183,278 $ 883 291,716 (108,649) (672)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (16,276)     (16,276)  
Restricted stock grant canceled (in shares)   (130,500)      
Restricted stock grant canceled 0 $ (1) 1    
Stock-based compensation 1,168   1,168    
Acquisition of subsidiary $ (100)   (772)   672
Ending Balance (in shares) at Mar. 31, 2026 88,117,442 88,117,442      
Ending Balance at Mar. 31, 2026 $ 168,070 $ 882 $ 292,113 $ (124,925) $ 0